Pulmonary Ionocytes Regulate CFTR-Mediated Chloride Transport in Human iPSC-Derived Epithelium
RATIONALE: Pulmonary ionocytes, representing approximately 1% of airway epithelial cells, exhibit high CFTR expression and unique transcriptional markers, including FOXI1, ASCL3, and V-ATPase. Their exact role in human airway physiology is incompletely understood. OBJECTIVE: This study employs induced pluripotent stem cell (iPSC)-derived airway epithelial models (iPSC-airways) to elucidate the role of FOXI1 in pulmonary ionocyte differentiation and function. METHODS: CRISPR-Cas9 was used to generate FOXI1-knockout iPSCs, into which a doxycycline-inducible FOXI1-overexpression cassette was introduced. Edited and control lines were differentiated into airway epithelia to evaluate ionocyte formation, epithelial composition, and ion transport. Rescue studies assessed the effects of FOXI1 re-expression in a FOXI1-KO background, and the addition of inducible WT-CFTR ionocytes to F508del/F508del cystic fibrosis (CF) cultures on restoring chloride transport. MEASUREMENTS AND MAIN RESULTS: FOXI1 deletion abolishes ionocyte formation and alters airway epithelial composition, with increased mucus-secreting goblet cells and decreased ciliated cells. Functional assays confirmed ionocytes as key regulators of chloride homeostasis, with FOXI1-deficient airways displaying diminished ion transport. Induction of FOXI1-overexpression restored CFTR-mediated chloride transport. Introduction of WT ionocytes into CF airway models rescued chloride transport deficits, with no rescue observed in vehicle-treated controls lacking ionocyte induction. CONCLUSIONS: These findings highlight FOXI1's essential role in pulmonary ionocyte development, airway cell composition, and airway chloride transport. We present a fully manipulable, gene-edited iPSC-derived system that enables investigation of ionocyte biology and function within a human airway context, highlighting them as promising therapeutic targets for respiratory disorders.
Authors
- Casey R. Johnson (ORCID: https://orcid.org/0000-0001-9948-1243)
- Jay R. Thiagarajah (ORCID: https://orcid.org/0000-0002-1437-325X)
- A. Fatima
- Darrell N. Kotton (ORCID: https://orcid.org/0000-0002-9604-8476)
- Thorsten M. Schlaeger (ORCID: https://orcid.org/0000-0002-1599-9908)
- Ruobing Wang (ORCID: https://orcid.org/0000-0003-0277-8329)
- Jianing Yin
- Alice Little
- Sharon Wu
- R.-L. Yeboah (ORCID: https://orcid.org/0009-0009-3212-4052)
- Yang Tang
- Stuart D Rollins
Institutions
- Boston University (US)
- Boston Medical Center (US)
- Boston Children's Hospital (US)
- Harvard University (US)
Publication Details
- Journal
- American Journal of Respiratory Cell and Molecular Biology
- Published
- 2026-11-13
- DOI
- https://doi.org/10.1093/ajrcmb/aanag219
- Primary Topic
- Cystic Fibrosis Research Advances
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Institutes of Health